COMPARATIVE STUDY OF GLIMEPIRIDE AND GLICLAZIDE IN TYPE 2 DIABETES PATIENTS ON SAFETY, EFFICACY AND TOLERABILITY

Journal Title: Journal of Drug Delivery and Therapeutics - Year 2015, Vol 5, Issue 3

Abstract

Background and Objective: Impaired glucose tolerance and impaired fasting glycaemia are risk categories for future development of diabetes and cardiovascular disease. Apart from being the leading cause of renal failure, it also increases the risk of lower limb amputations, visual impairment and tuberculosis. Higher incidence of Diabetes Mellitus in the last decade has compelled us to conduct the present study with an objective to establish safety, efficacy and tolerability of gliclazide against glimepiride in the treatment of type 2 Diabetes Mellitus. Methodology: The present study was single centered, prospective and observational conducted after obtaining approval from the ethics committee. A total of 40 patients who visited the outpatient block of Apollo hospital at Jubilee Hills, Hyderabad were enrolled in the study. A questionnaire was used to record the response of subjects participated in the study. Results: A higher proportion of patients belonged to the age group of 41-50 years. Gliclazide did not result in any ADR while glimepiride caused eight ADRs. Average reduction of FBS and PPBS in gliclazide group was found to be 52.5% and 41.3% respectively. Corresponding figures for glimepiride were 56.9% and 32.3%. HbA1c reduction in gliclazide and glimepiride group was 2.44 and 1.91 respectively. Both drugs were found to be well tolerated by the patients. Conclusion: Gliclazide was found to be superior in terms of safety and efficacy. Hence it can be concluded from the study that gliclazide is a better option in diabetes when compared to glimepiride.

Authors and Affiliations

Raju Chipirishetti

Keywords

Related Articles

ANTIPROLIFERATIVE AND APOPTOGENIC EFFICACY OF ANTIDIABETIC DRUGS METFORMIN AND SITAGLIPTIN AGAINST MCF7 AND HEPG2 CANCER CELLS: A COMPARATIVE MOLECULAR STUDY

Lifestyle and diet-related disorder type 2 diabetes (T2D), has reached epidemic margin globally. The relationships between diabetes and cancer are complex. However, evidence supports the hypothesis that obesity raises th...

KNOWLEDGE, ATTITUDE AND PRACTICES ON ANTIBIOTIC USE AND RESISTANCE AMONG DOCTORS IN B.P. KOIRALA INSTITUTE OF HEALTH SCIENCES

Background: Assessment of knowledge, attitudes and practices (KAP) of antibiotic prescription among doctors may help in developing guidelines to improve antibiotics use and decrease resistance. Aims and objectives: Our...

THEILERIOSIS IN BUFFALO: A CASE STUDY

Bovine theileriosis is caused by the protozoan parasite Theileria annulata and Theileria parva and is transmitted through tick Hyalomma and Rhipicephalus, respectively leading to economic losses and causes devastating lo...

CURRENT GOOD MANUFACTURING GUIDELINES FOR MEDICINAL PRODUCT

The holder of a manufacturing authorisation must manufacture medicinal products so as to ensure that they are fit for their intended use, comply with the requirements of the Marketing Authorisation and do not place pat...

A study to assess knowledge regarding fatty liver among bank employees working in selected banks at Mangaluru

Background: Fatty liver is closely associated with lifestyle. The bank employees have been often witnessed having junk food, coming home late and not engaged in any physical activity. Hence, an attempt has been made by t...

Download PDF file
  • EP ID EP214877
  • DOI 10.22270/jddt.v5i3.1141
  • Views 112
  • Downloads 0

How To Cite

Raju Chipirishetti (2015). COMPARATIVE STUDY OF GLIMEPIRIDE AND GLICLAZIDE IN TYPE 2 DIABETES PATIENTS ON SAFETY, EFFICACY AND TOLERABILITY. Journal of Drug Delivery and Therapeutics, 5(3), -. https://europub.co.uk/articles/-A-214877